There is a forecast that the KOSDAQ index could rise to 1,100 next year. The main reasons cited are the increase in operating profits of listed companies and the inflow of capital from policy funds.


In particular, the bio and healthcare sectors are expected to grow due to increased revenue from new drug technology licensing fees and higher sales of beauty devices. Government funds such as the Fund of Funds and the National Growth Fund are also expected to flow into KOSDAQ via the venture and high-tech industries, simultaneously boosting both earnings visibility and valuations.


Additionally, institutional improvements such as the mandatory tender offer system are expected to help protect minority shareholders and invigorate M&A activity, which will have a positive impact on the KOSDAQ market.

KOSDAQ to Reach 1,100? Investors Focus on Policy and Bio Momentum View original image

[Industry Leader HighStockLoan Direct Link: https://www.hisl.co.kr/5113]


Meanwhile, interest in stock loans continues to grow. This is because investors who do not want to miss out on rare investment opportunities are turning to stock loans, which allow them to utilize more capital for stock purchases.


Another advantage of stock loans is that, even if investors face a forced sale crisis due to a sharp drop in stock prices while using margin/credit, they can simply switch to a stock loan without providing additional collateral or selling their holdings, and then wait for a market rebound.


◆ HighStockLoan: Annual Interest Rates in the 4% Range, the Industry's Lowest, for Additional Investment Funds and Credit/Margin Refinancing!

HighStockLoan has launched a securities-linked credit product with the industry's lowest annual interest rates in the 4% range, allowing anyone to experience stock loans without burden. It can be used not only for stock purchases but also for refinancing margin/credit at securities firms, and up to four times the investor's own capital can be utilized regardless of credit rating.


In addition, for investors who have had difficulty using stock loans due to DSR limits, products that can be used regardless of DSR are also available. Investors using the alternative trading system (NXT) can also take advantage of these offerings.


Investors who want to learn more about HighStockLoan's diverse and customized products can contact the customer service center (☎1566-5113) for convenient consultation with a professional advisor 24 hours a day, regardless of loan approval.


○ Launch of products with the industry's lowest annual interest rates in the 4% range

○ Products available regardless of DSR

○ Ranked No. 1 in market share for 21 consecutive years, and recipient of the Korea First Brand Award for 16 consecutive years

○ Real-time repayment of margin/credit at securities firms

○ Available for trading on the alternative trading system (NXT)

○ Reliable consultation quality guarantee system

* HighStockLoan Consultation Center: 1566-5113

Direct Link: https://www.hisl.co.kr/5113


Immunoncia, Nota, Innotech, Graphy, Samhyun



※ The above content is unrelated to the editorial direction of The Asia Business Daily, and all responsibility lies with the information provider.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing